je.st
news
Tag: ipos
IPOs and IPAs: Ballast Point Transaction Illustrates Benefits of a Dual-Track Approach
2015-11-27 04:58:26| Beverages - Topix.net
The menu for craft breweries raising capital and looking for investor liquidity now includes another viable alternative - public offerings. With the filing of public offering documents by Ballast Point Brewing & Spirits and the positive reception it received, those watching the industry should be on notice that more craft beer IPOs are on the horizon.
Tags: point
approach
benefits
transaction
Diller's Tinder Stock Offering Seeks to Buck Down Year in IPOs
2015-10-27 13:05:47| Apparel - Topix.net
Barry Diller always wants to be different. While equity investors have mostly snubbed initial public offerings in 2015 , the media mogul Barry Diller, ever the contrarian, is betting he has what it takes to please the market.
Tags: year
stock
offering
seeks
Pharma IPOs grind to a halt as biotech stock rout rattles investors
2015-10-11 06:54:25| Biotech - Topix.net
U.S. Democratic presidential candidate Hillary Clinton speaks during a community forum campaign event at Cornell College in Mt Vernon, Iowa, October 7, 2015. REUTERS/Scott Morgan The biotechnology sector's two-and-a-half-year deluge of public market debuts, with dozens of companies raising billions of dollars in funding, has ground to a halt.
Tags: stock
investors
ipos
halt
The Daily Startup: Market Turbulence Puts Biotech IPOs in Question
2015-10-09 05:44:57| Biotech - Topix.net
A nearly three-month slide in the biotechnology market is prompting some venture capitalists to wonder if drug startups' sprint to the Nasdaq will slow to a crawl, Brian Gormley reports for Dow Jones VentureWire. Since late July, the Nasdaq Biotechnology Index has slipped nearly 23% amid a general market decline and the fallout from Turing Pharmaceuticals AG 's decision to hike the price of a rare-disease drug-a decision the company has since reversed.
Tags: question
market
daily
puts
Biotech IPOs Slow to Trickle as Stock Rout Rattles Investors
2015-10-08 20:25:02| Biotech - Topix.net
The biotechnology sector's two-and-a-half-year deluge of public market debuts, with dozens of companies raising billions of dollars in funding, is now down to a trickle. After CytomX Therapeutics Inc. priced its initial public offering late Wednesday, not a single biomedical, drug or therapeutics company is expected to follow suit in the next 30 days.
Tags: stock
slow
investors
ipos
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] next »